Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
Active substance renewal under the GB Biocidal Products Regulation (GB BPR) is a critical regulatory challenge for companies placing biocidal products on the Great Britain market. With strict 550-day submission deadlines and major expiries in 2026 and 2027, early planning is essential to avoid market disruption and loss of product authorisations.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
The European Commission is opening a consultation until 28 January 2017 on the evaluation of the REACH regulation as part of the Refit program to review the quality of European legislation in force. The aim of this consultation? Gather the views of stakeholders on the approach to this assessment as well as on the strengths and weaknesses of the current regulations in preparation for their next revision.
The FDA banned 19 active substances in antibacterial soaps due to lack of safety and effectiveness data. Consumers are advised to use plain soap and water instead. Some producers have already removed the banned substances from their products.
The European cosmetics industry is highly regulated to ensure consumer safety, with claims on products needing to meet six criteria under regulation 655/2013. Authorities monitor compliance, focusing on truthfulness and fairness, to prevent misleading marketing.
The European market lacks investment in SVHC substitution, hindering progress. The Lowell centre recommends building infrastructures, increasing engagement, and enhancing technical capacity to support the analysis of alternatives. Authorities face challenges in identifying, evaluating, and adopting SVHC substitution. ECHA can play a key role in supporting these initiatives. For more information on SVHCs, visit our website.
Comparison of US and EU cosmetic regulations: US focuses on FDA laws like FD&C Act, while EU Regulation 1223/2009 emphasizes safety, good practices, and market surveillance. Labeling requirements differ, with US requiring more detailed information.
ECHA predicts a surge in REACH registrations, with 60,000 dossiers expected for 25,000 substances. Germany leads in registrations, with SMEs taking on more roles. Learn the benefits of being a Lead registrant and the importance of timely registration.
